Selin Kurnaz is an accomplished entrepreneur, engineer, and healthcare innovator, best known as the Co-Founder and CEO of Massive Bio, a global technology company dedicated to expanding access to cancer clinical trials. With a strong academic foundation that includes multiple engineering degrees, Kurnaz brings deep expertise to the intersection of technology and healthcare. Prior to founding Massive Bio, she spent over a decade in management consulting and played a key role in establishing EY’s Private Equity Value Creation team, advising healthcare investments and operational strategy. Under her leadership, Massive Bio has developed AI-driven platforms that connect cancer patients, physicians, and pharmaceutical companies to clinical trial and commercial opportunities worldwide, helping overcome geographic and financial barriers to advanced treatments. Recognized among the 100 Most Influential CEOs in Oncology, Kurnaz is widely regarded as a visionary leader committed to transforming global oncology access and accelerating the adoption of precision medicine.